Hester Biosciences Limited has informed the Exchange about Change in KMPs Authorisation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has informed the stock exchange about a change in the authorisation of Key Managerial Personnel (KMPs) under Regulation 30(5) of SEBI's Listing Obligations and Disclosure Requirements, 2015. This regulation requires listed companies to designate specific KMPs who are authorised to determine the materiality of events and make timely disclosures to the exchange. The filing signals an update to which executives are now responsible for compliance and disclosure duties at the company. No specific financial numbers or detailed event information is mentioned in the headline.
This is largely a procedural governance update regarding disclosure responsibilities and is unlikely to have any direct material impact on shareholders or the stock price. Investors may want to monitor the company for follow-up filings that clarify whether this change is linked to any senior management departure or new appointment.